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Objectives: We evaluated the pattern of nodal metastasis and its prognosis 
after radical lymphadenectomy in adenocarcinoma of the gastric cardia. 
Methods: We conducted a retrospective cohort study of 70 patients (52 men 
and 18 women; mean age 63.6 years) with adenocarcinomas of the gastric 
cardia who underwent extended gastrectomy (65 total gastrectomies and 5 
proximal gastrectomies) and radical lymphadenectomy (D2 to D4) at 
Taichung Veterans General Hospital between 1989 and 1995. Results: 
Twenty-four complications developed in 22 (31.4%) patients, and seven 
(10.0%) hospital deaths occurred. An overall 5-year cumulative survival of 
37.6% was obtained. Lymph node metastases were identified in 53 (75.7%) 
patients. Nodal involvement was closely related to the depth of tumor 
invasion (p = 0.005). When the gastric wall invasion was limited to the 
subserosal ayer (T1 and T2, n = 15), no patient had N4 group nodal 
metastasis. Once the serosal ayer had been involved (beyond T3), N4 group 
nodal metastasis was frequently seen (30.9%, 17 of 55 patients). A multi- 
variable analysis revealed that the level of nodal involvement, the depth of 
tumor invasion, and the presence of complications were independent 
prognostic factors. Cumulative 5-year survivals of curability A (n = 12), B 
(n = 19), and C (n = 32) resections were 100%, 21.2%, and 27.5%, 
respectively (p = 0.0001). The long-term survival of the patients after 
resection was also closely related to their pTNM stages (p = 0.0004). 
Conclusions: We conclude that gastrectomy accompanied by radical lymph- 
adenectomy provides a reasonable long-term survival expectancy that is 
closely related to the stage of the disease and the curability of resection. 
(J Thorac Cardiovasc Surg 1997;114:544-51) 
S urgical resection is the treatment of choice for cancer of the stomach if no distant metastases 
exist. Japanese experience further confirms the 
importance of radical lymph node dissection in 
addition to gastrectomy. 1' 2 Cancer of the gastric 
cardia accounts for 5% to 25% of gastric can- 
cers. 2-4 Its prevalence has been steadily increasing 
in Western countries in recent years. 5 Different 
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surgical approaches have been applied to tumors 
of this particular anatomic site, focusing on either 
the thoracic side or the abdominal side. For a long 
period (before 1989), we performed tumor resec- 
tions of the gastric cardia either through separate 
abdominal and thoracic incisions or through a 
thoracoabdominal incision with D1 to D2 lymph 
node dissection. However, experience showed that 
intrathoracic lymphatic spread up to the subcari- 
nal level is unusual. 6 Besides, with the use of the 
EEA stapling device (Auto Suture Company Di- 
vision, United States Surgical Corporation, Nor- 
walk, Conn.), a satisfactory segment of the distal 
esophagus can be resected and anastomosed 
safely. Since 1989, the majority of surgical resec- 
tions for adenocarcinoma of the gastric cardia in 
this institute have been performed exclusively 
through the abdominal side. This retrospective 
cohort study presents our recent experience and 
results in treating adenocarcinoma of the gastric 
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Table I. The clinical details of 70 cases of 
adenocarcinoma of the gastric cardia 
Patients 
Variables No. % 
Sex 
Male 52 74.3 
Female 18 25.7 
Gastrectomy 
Total 63 90.0 
Proximal 7 10.0 
Complication 
Yes 22 31.4 
No 48 68.6 
Hospital mortality 
Yes 7 10.0 
No 63 90.0 
Current status 
Alive 29 44.3 
Dead 41 55.7 
Lymph node dissection 
D 5 7.1 
D3 5 7.1 
D4 60 85.8 
Curabiliw 
A 12 17.1 
B 21 30.0 
C 37 52.9 
T stage 
TI 8 11.4 
T2 7 10.0 
T3 23 32.9 
T4 32 45.7 
N stage 
N0 17 24.3 
N1 18 25.7 
N2 17 24.3 
N3 1 1.4 
N4 17 24.3 
Stage 
Ia 6 8.6 
Jb 3 4.3 
II 8 11.4 
IIIa 13 18.6 
IIIb 17 24.3 
IV 23 32.9 
card ia  by an abdomina l  approach  with gastrec-  
tomy and radica l  l ymphadenectomy (D2 to D4). 
Patients and methods 
Between January 1, 1989, and December 31, 1995, 392 
patients with adenocarcinoma of the stomach, who under- 
went extended gastrectomy and radical ymphadenectomy 
(D2 to D4) at Taichung Veterans General Hospital, were 
included in this retrospective cohort study. The exclusion 
criteria for radical lymphadenectomy includes dissemi- 
nated peritoneal tumor seeding, multiple organ invasion, 
and poor cardiopulmonary function of the patient. Among 
Table I I .  Classification of nodal station for 
adenocarcinoma of the gastric cardia 
Group Station Name 
N1 1 Right cardiac 
2 Left cardiac 
3 Lesser curvature 
4 Greater curvature 
N2 5 Suprapyloric 
6 Infrapyloric 
7 Left gastric artery 
8 Common hepatic artery 
9 Celiac artery 
10 Splenic hilum 
11 Splenic artery 
N3 12 Hepatoduodenal ligament 
13 Retropancreatic 
14 Mesenteric root 
N4 15 Middle colic artery 
16 Paraaortic nodes 
these, 70 consecutive patients with adenocarcinoma of the 
gastric cardia were enrolled in this study. The group 
comprised 52 men and 18 women. The mean ages at 
diagnosis for male and female patients were 65.8 years 
and 57.0 years, respectively. Table I shows the demo- 
graphic data of these patients. 
The majority of the operations were carried out exclu- 
sively through the abdominal side. Except for five proxi- 
mal gastrectomies, a total gastrectomy was performed in 
all patients. The pancreas was preserved uring lymph 
node dissection unless it was directly involved by the 
tumor. The alimentary continuity was restored by a Roux- 
en-Y esophagojejunostomy accomplished with a 25F EEA 
stapler. The definition of nodal station (Table II) and 
curability of resection for carcinoma of the gastric cardia 
as set up by the Japanese Research Society for Gastric 
Cancer were adopted in this study. 7In brief, group 1 to 4 
nodes, group 5 to 11 nodes, group 12 to 14 nodes, and 
group 15 and 16 nodes were classified as N1, N2, N3, and 
N4 groups, respectively. D2 stands for lymphadenectomy 
of the N1 and N2 groups; D3 stands for lymphadenectomy 
of the N1, N2, and N3 groups; and D4 stands for 
lymphadenectomy of the N1, N2, N3, and N4 groups. 
Patients with a T1 or T2 lesion, with the nodal metastasis 
confined to N1 group (NO or N1), with an adequate 
lymphadenectomy (->D1 for NO, ->D2 for N1), and with- 
out peritoneal seeding (P0), liver invasion (H0), or distant 
metastasis (M0) who underwent gastric resection with a 
microscopically safe margin (---5 ram) were classified as 
having curability A resection. Patients with peritoneal 
seeding, direct contagious organ invasion (T4) even after 
complete resection, or residual tumor were classified as 
having curability C resection. Patients in between were 
classified as having curability B resection. No patient was 
lost to follow-up in the study period. All of the current 
survivors have been followed up for more than 12 months 
(12 to 81 months). 
Survival probabilities were estimated by means of the 
Kaplan-Meier product-limit method. 8 The log-rank test 
was used to interpret he statistical difference between 
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Table III. Details of complications and causes 
of death 
Episodes 
No. % 
Complications 24 3&3 
Pancreatic fistula 6 8.6 
Abdominal abscess 6 8.6 
Anastomotic leak 3 4.3 
Respiratory failure 2 2.9 
Wound infection 2 2.9 
Upper GI bleeding 1 1.4 
Lymphatic leak 1 1.4 
Bile leak 1 1.4 
Suffocation 1 1.4 
Cerebral vascular accident 1 1.4 
Deaths 7 10.0 
Sepsis 3 4.3 
Anastomotic leak 1 1.4 
Pancreatic fistula 1 1.4 
Abdominal abscess 1 1.4 
Respiratory failure 1 1.4 
Suffocation 1 1.4 
Massive upper gastrointestinal bleeding 1 1.4 
Cerebral vascular accident 1 1.4 
*A total of 24 complications developed in 22 patients. 
survival curves. The Cox proportional hazards model, s
assessed by the survival data of all 70 patients, was used 
for multivariable survival analysis in the manner of for- 
ward stepwise regression. The covariates were assigned to 
the model until the log-likelihood ratio stopped improving 
over the previous tep at a 0.05 level. Then the prognostic 
factors were entered into the multivariable model, which 
offered a predictive relative hazards of mortality for the 
selected factors. 
The association of an ordinal categoric response 
variable to a covariate was measured by the propor- 
tional odds model. 9 The statistical significance of the 
relationship was assessed by likelihood ratio tests. The 
odds ratio of one unit increment in the covariate was 
derived from the model and evaluated the change of 
odds for patients likely to lie in higher levels of the 
ordinal response variable. 
Survivals, Cox's model, and the proportional odds 
model were calculated by the 1L, 2L, and PR programs, 
respectively, in the BMDP statistical software. 1° 
Results 
Current status of the patients. At the end point of 
this study (December 31, 1996), 29 patients were still 
alive and 41 patients had died. No patient was lost to 
follow-up. All of the patients had been followed up for 
at least 12 months (12 to 81 months). 
Complications and deaths. There were 24 com- 
plications (34.3%), which occurred in 22 patients 
(31.4%), and seven hospital deaths (10.0%). The 
causes of complications and deaths are listed in 
Table III. The most common complications in- 
cluded pancreatic fistula and abdominal abscess, 
and the leading cause of death was sepsis. 
Extent of radical lymph node dissection. Except 
in 10 patients with T1 or T2 tumors, all patients 
underwent lymph node dissection up to (and 
including) the N4 group. The types of lymphade- 
nectomy included D2 in five patients, D3 in five, 
and D4 in 60. The details concerning the number 
of lymph nodes that were removed and involved 
by the tumor are listed in Table IV, A total of 
3121 (average 44.6 in 70 patients) lymph nodes 
were resected, and 691 (average 13.0 in 53 pa- 
tients) lymph nodes had metastases. None of the 
D2 group had N2 group lymph node metastasis. 
One of the D3 group had N3 group lymph node 
metastasis. The relation between the extent of the 
lymphadenectomy and nodal metastasis  listed in 
Table V (p = 0.008). The odds ratio of D4 to 
D2+D3 was 5.9 (95% confidence interval [CI] was 
1.5 to 23.0). This showed that patients who under- 
went D4 dissection were 5.9 times more likely to 
have nodal metastases than patients having 
D2+D3 dissection. 
Depth of tumor invasion and its relation to lymph 
node metastasis. Early gastric cancer was found in 
eight patients (11.4%, mucosa in three and submu- 
cosa in five). Fifty-three (75.7%) patients had lymph 
node metastasis. The rates of lymph node metastasis 
in T1 through T4 lesions were 25.0%, 71.4%, 82.6%, 
and 84.4%, respectively. The level of lymph node 
involvement was positively related to the depth of 
tumor invasion, as shown in Table V (p = 0.005). 
The odds ratios of T3 and T4 to T I+T2 were 4.7 
(95% CI was 1.4 to 17.0) and 6.8 (95% CI was 2.0 to 
23.0), respectively. The 5-year cumulative survivals 
of patients with T1 through T4 lesions were 100%, 
71.4%, 27.8%, and 20.1%, respectively. The 5-year 
cumulative survivals of patients with node-negative 
and node-positive disease were 68.4% and 27.5%, 
respectively. 
Curability of resection. Curability A resections 
were accomplished in 12 patients, curability B resec- 
tions in 21 patients, and curability C resections in 37 
patients. The 5-year cumulative survivals of patients 
having curability A, B, and C resections were 100%, 
21.2%, and 27.5%, respectively. Curability A resec- 
tions had a better prognosis than B and C resections 
(curability A vs curability B,p = 0.0003; curability A
vs curability C, p = 0.00005). 
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Table IV. The details of lymphadenectomy according to 16 individual nodal stations 
Node dissected/patients Node with metastasis/patients 
Nodal station (mean) (mean) 
1. Right cardiac 274/61 (4.5) 111/35 (3.2) 
2. Left cardiac 148/43 (3.4) 37/20 (1.9) 
3. Lesser curvature 406/65 (6.2) 154/41 (3.8) 
4. Greater curvature 283/55 (5.1) 84/19 (4.4) 
5. Suprapyloric 56/29 (1.9) 8/6 (1.3) 
6. Infrapyloric 244/54 (4.5) 18/8 (2.2) 
7. Left gastric artery 165/57 (2.9) 38/20 (1.9) 
8. Common hepatic artery 283/62 (4.6) 45/17 (2.6) 
9. Celiac artery 155/49 (3.2) 11/8 (1.4) 
i0. Splenic hilum 117/35 (3.3) 28/13 (2.2) 
11. Splenic artery 206/53 (3.9) 61/19 (3.2) 
!2. Hepatoduodenal ligament 179/50 (3.6) 14/7 (2.0) 
13. Retropancreatic 75/37 (2.0) 7/3 (2.3) 
14. Mesenteric root 26/13 (2.0) 6/3 (2.0) 
I5. Middle colic artery 13/7 (1.9) 6/3 (2.0) 
16. Paraaortic nodes 493/57 (8.6) 63/15 (4.2) 
Total 3123/70 (44.6) 691/53 (13.0) 
Table V. Relationship of the nodal metastasis with extent of lymphadenectomy and depth of tumor invasion in 
proportional odds model 
Lymph node metastasis 
Factors NO N1 N2 3[3 + 4 Proportional odds ratio 95% CI p Values 
Lymph adenectomy 
D2 + D3 6 2 1 1 1 
D4 11 16 16 17 5.9 1.5 to 23.0 
Depth of invasion 
T1 + T2 8 4 2 1 1 
T3 4 7 6 6 4.7 1.4 to 17,0 
T4 5 7 9 11 6.8 2.0 to 23,0 
0.008 
0.005 
CI, Confidence interval. 
TNM stage of the tumor. The clinicopathologic 
TNM stages of the patients were as follows: stage 
Ia, six patients; stage Ib, three patients; stage II, 
eight patients; stage IIIa, 13 patients; stage IIIb, 
17 patients; and stage IV, 23 patients. The overall 
cumulative survival curve is shown in Fig. 1, with 
a 5-year survival of 37.6%. The 5-year cumulative 
survivals in patients in pTNM stages I through IV 
were 100%, 62.5%, 23.0%, and 17.4%, respec- 
tively (p = 0.0004). 
Prognostic factors. Multivariable survival analy- 
sis by Cox's proportional hazards model revealed 
that the level of nodal invasion (p = 0.02), the depth 
of tumor invasion (p = 0.01), and the presence of 
complications (p = 0.002) were independent prog- 
nostic factors. The relative hazards relating mortal- 
ity to a prognostic factor with the adjustment of 
other factors are shown in Table VI. 
Long-term follow-up and causes of death. At the 
end point of this study, 41 patients had died. Most 
of them died of systemic metastasis. No recur- 
rences developed at the site of the esophageal 
anastomosis in our series, even though one patient 
had a diseased cut margin on pathologic exami- 
nation. Another patient had severe gastroesopha- 
gem reflux after a proximal gastrectomy followed 
by esophagogastrostomy. A completion totai gas- 
trectomy was performed 21 months after the first 
operation, with recurrent umor being found by 
chance at the gastric remnant. Nine months later, 
he underwent a third operation (transhiatal 
esophagectomy and colon interposition) because 
of tumor recurrence at the lower esophagus. This 
patient was still doing well 10 months after the 
third operation. None of the patients who under- 
went total gastrectomy followed by Roux-en-Y 
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Fig. 1. Overall survivals in adenocarcinoma of the gastric ardia after radical ymphadenectomy. 
esophagojejunostomy had symptomatic esopha- 
geal regurgitation. 
Discussion 
The incidence of carcinoma of the gastric cardia 
has increased steadily in recent years, especially in 
Western countries, ' it, 12 Various definitions have 
been used to describe the "gastric cardia. ''4' i3, i4 In 
this report, we use a broader definition based on the 
criteria proposed by the Japanese Research Society 
for Gastric Cancer. 7 During the study period, 392 
gastric carcinomas were managed by radical ymph- 
adenectomy in this institute, and 70 (17.9%) of them 
were adenocarcinoma of the gastric cardia. The 
prevalence of adenocarcinoma of the gastric cardia 
was roughly as reported by others. 2' 3 
The generally accepted concept of severe gastro- 
esophageal reflux after proximal gastrectomy has lim- 
ited its clinical popularity in recent years. Is Besides, 
both inadequate surgical margins and limitations of 
lymphadenectomy are potential drawbacks. Five of 
our patients received a proximal gastrectomy; never- 
theless, all of them had lymph node dissection up to 
the N4 group. Most of our patients (92.9%) received a
total gastrectomy and Roux-en-Y type esophagojeju- 
nostomy to restore digestive tract continuity. All of the 
patients who underwent proximal gastrectomy (n = 5) 
had various degrees of gastroesophageal ref ux. How- 
ever, none of the patients who underwent total gas- 
trectomy had symptoms of gastroesophageal reflux 
after a Roux-en-Y esophagojejunostomy or its modi- 
fications for bile diversion. It is still debatable whether 
to perform a combined resection of the spleen and 
pancreas.i, 16, 17 Unless the pancreas is directly in- 
volved by the tumor, we prefer to perform a pancreas- 
preserving splenectomy during gastrectomy, as pro- 
posed by Maruyama and colleagues. 18 Tumor 
metastases to the splenic hilum and splenic artery were 
observed in 13.6% and 25.4% of the patients, respec- 
tively. Six (8.6%) pancreatic fistulas developed, one of 
which caused ahospital death. All of them occurred in 
patients who received a distal pancreatectomy. Our 
experience showed that a routine distal pancreatec- 
tomy is not necessary for lymph node dissection at the 
splenic hilum, pancreatic tail, and along the course of 
the splenic artery. Adequate lymphadenectomy can be 
obtained, and pancreatic fistula can be avoided. 
Great concern about the length of distal esopha- 
gectomy has been raised and emphasized. 3' 19-21 
However, others have preferred an abdominal ap- 
proach for resection of carcinoma of the gastric 
cardia.1, 2, 22 We believe that the type of operation is 
basically dependent on the type of tumor and its 
extent of esophageal involvementY In Western 
countries, more type I cancers of the cardia (origi- 
nating from Barrett's epithelium) were encoun- 
tered, although most of our cardJa cancers were 
either type II or type Ill instead. We had only one 
proved case of Barrett's esophagus inducing early 
adenocarcinoma of the cardia in this series. Since 
1989, the majority of gastrectomies for adenocarcj- 
noma of the gastric cardia have been performed 
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exclusively through an abdominal approach. We 
found that resection of the distal esophagus through 
an enlarged hiatus is not difficult. Usually the esoph- 
agus can be transected at least 3 to 6 cm above the 
tumor border. The digestive continuity then can be 
restored by an EEA stapler instead of by hand 
sewing. With this approach, respiratory complica- 
tions can be minimized, and the likelihood of anas- 
tomotic leakage can be lowered when compared 
with results of previous experience (4.3% vs 7.6%, 
p = 0.4). 24 Residual tumor on the esophageal cut 
margin or anastomotic recurrence was not a major 
problem in our series. Only one of our patients had 
a microscopically diseased esophageal cut end on 
pathologic examination. Postoperative irradiation 
was implemented, and local recurrence did not 
develop before he died of liver metastasis. Further- 
more, none of the patients had tumor recurrence at 
the residual esophageal segment. We believe long- 
distance submucosal tumor infiltration in adenocar- 
cinoma of the gastric ardia is not so frequently seen 
as it is in squamous cell carcinoma of the esophagus. 
A safe margin of 3 to 6 cm above the tumor is 
mandatory. Another reason for adopting a transab- 
dominal approach emanates from a report from one 
of our associated hospitals, which demonstrated 
zero incidence of lymph node metastasis at the 
subcarinal region. 6 We therefore recommend a 
transabdominal approach for resection of adenocar- 
cinoma of the gastric cardia. 
The importance of radical lymphadenectomy 
has been repeatedly emphasized, especially in the 
Japanese series. 1' 2, 25 Its benefits had even been 
pointed out in node-negative early gastric carci- 
noma and in noncurative gastrectomy. 26'27 The 
adequacy of lymphadenectomy in this series can 
be proved by an average of 44.6 dissected nodes 
per patient. D2 dissection was performed in five 
patients (T1 in three, T2 in two), and none of 
them had N2 metastasis. D3 dissection was per- 
formed in five patients (T1 in four, T3 in one), and 
only one patient had N3 metastasis. The remain- 
der (n = 60, 85.7%) received radical lymphade- 
nectomy to the paraaortic region. Complications 
related to lymphadenectomy were pancreatic fis- 
tula, abdominal abscess, and prolonged lymphatic 
leak. The overall complication and mortality rates 
of 31.4% and 10.0% were higher than in our 
previous experience (17.4%, p = 0.009; 5.9%, p = 
0.3), but they were similar to the Dutch experi- 
ences. 28 
Our data furthermore demonstrated that the level 
Table VI. Multivariable survival analysis by Cox's 
proportional hazards model (n = 70) 
Variables Hazard ratio 95% CI p Values 
Lymph node metastasis 0.02 
NO 1 
N1 0.89 0.28 to 2.81 
N2 2.13 0.73 to 6.24 
N3 + N4 3.45 1.18 to 10.04 
Depth of invasion 0.0t 
T1 + T2 1 
T3 7.78 1.70 to 35.68 
T4 9.69 2.10 to 44.70 
Complication 
No 1 
Yes 2.81 1.45 to 5,45 0.002 
CI, Confidence interval. 
of nodal metastasis  closely related to the depth of 
tumor invasion (p = 0.005), as reported by oth- 
ers.29, 3o Moreover, multivariable analysis revealed 
that both the T factor and N factor are independent 
prognostic factors, as they were in the German 
report. 31 The prognoses of patients with T3 to T4 
tumors or patients with N3 to N4 nodal metastasis 
are much worse than the prognoses of their coun- 
terparts. 
Not only the stage of the tumor, but also the 
degree of curability in resection is important for 
prognostic prediction. A curability A resection pro- 
vides the best opportunity for long-term survival. 
According to the definition of the Japanese Re- 
search Society for Gastric Cancer, only patients with 
a T1 or T2 lesion, with their nodal metastasis 
confined to N1 group (NO or N1), with an adequate 
lymphadenectomy (->D1 for NO, ->D2 for N1), and 
without peritoneal seeding (P0), liver invasion (H0), 
or distant metastasis (M0), and who underwent 
gastric resection with a microscopically safe margin 
(->5 mm) can be classified as having had a curability 
A resection. Unlike the Japanese reports, the diag- 
nosis in most of our patients was made at a relatively 
late stage. Only 12 (17.1%) procedures can be 
classified as curability A resections. On the contrary, 
more than half (n = 37, 52.9%) of our patients 
received a curability C resection. The main reason 
for the stage of disease being classified as advanced 
was detection of T4 lesion or direct invasion of the 
regional omentum or mesocolon by the tumor dur- 
ing the operation. Both of these factors subse- 
quently led to an overall poorer outcome. Early 
diagnosis provides the only way to achieve acurabil- 
ity A resection and long-term survival. 
Early gastric cancers (mucosa and submucosa) 
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were identified in eight patients; however, only six of 
them had node-negative disease (stage Ia). This 
group of patients, together with those having T2 NO 
and T1 N1 (stage lb, n = 3) disease, all had a 100% 
survival at 5 years. Once the tumor invaded beyond 
the submucosal layer (T3 and T4 lesions), 82.3% (51 
of 62 patients) of the patients in this series had 
nodal involvement. Except in T1 tumor, our data 
support a radical ymphadenectomy to achieve com- 
plete tumor resection. Besides, accurate tumor stag- 
ing can be obtained only through a thorough lymph- 
adenectomy. This is also essential for elimination of 
the stage migration phenomenon. 32-An overall 5- 
year survival of 37.6% was obtained in this series, 
which was much better than a previous report from 
this institute (6.7% 5-year survival). 24 To some 
extent, we believe that the changes in our attitude 
toward adenocarcinoma of the gastric cardia, using 
a more radical intraabdominal lymphadenectomy in 
addition to extended gastrectomy, contributed to 
the better outcome in this series. Comparison of the 
survivals revealed statistically significant survival dif- 
ferences among different stages (p = 0.0004). Pa- 
tients with stage I and stage II tumors had 5-year 
survivals of 100.0% and 62.5%, respectively. A
tumor of stage IIIa or above indicates a poor 
prognosis, but the results in this study are still better 
than our previous results. 
Long-term follow-up of the patients revealed that 
the majority died of systemic metastasis. Local re- 
currence at the esophageal nastomotic site was not 
observed if an adequate length (more than 3 cm) 
was excised. However, a local recurrence did de- 
velop at the gastric remnant after a proximal gas- 
trectomy in one patient. Despite a completion total 
gastrectomy, a local recurrence still developed at the 
lower end of the esophagus, which led to a trans- 
hiatal esophagectomy and colon interposition, as 
described in the Results section. Thus a proximal 
gastrectomy should be avoided whenever possible, 
not only to eliminate gastroesophageal reflux, but 
also to prevent tumor recurrence at the gastric 
remnant. 
Our experience demonstrates that through an 
abdominal approach (extended gastrectomy includ- 
ing distal esophagectomy), radical lymphadenec- 
tomy can be safely performed with an acceptable 
morbidity and mortality rate. Esophagojejunostomy 
with an EEA stapler through an enlarged esopha- 
geal hiatus significantly decreased the prevalence of 
anastomotic leak. However, increased intraabdomi- 
nal complications associated with radical lymphad- 
enectomy were observed. Long-term survival of 
these patients was dramatically improved in this 
institute by a more aggressive attitude with the use 
of extended gastrectomy and radical lymphadenec- 
tomy for adenocarcinoma of the gastric cardia. 
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